Clinical Characteristics, Anti-hyperglycaemic Treatment Pattern and Target Attainment of Type 2 Diabetes Mellitus Patients in Older Population With or Without Albuminuria in China
NCT ID: NCT03064841
Last Updated: 2019-08-28
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1537 participants
OBSERVATIONAL
2017-03-09
2017-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comprehensive Longitudinal Cohort Study in Type 2 Diabetes With High Risk of Cardiovascular Diseases in China
NCT01307410
Nationwide Assessment of Cardiovascular Risk Factors: in Chinese Patients With Type 2 Diabetes
NCT01128205
HbA1c Prediction Model in Patients With Type 2 Diabetes
NCT05824286
Cohort Study in Type 2 Diabetes in China
NCT01076023
Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)
NCT03024788
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Outpatient with confirmed T2DM
subjects with confirmed T2DM
No Treatment
No treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No Treatment
No treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient with confirmed T2DM (According to the American Diabetes Association criteria 2015 \[R16-1532\])
* Ageā„60 years
Exclusion Criteria
* Patients who are participating in any other clinical study, including any questionnaire-based study, any interventional study (including diet/counselling based intervention), or any clinical study in which any medications (including Chinese herbal medications) are administered
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boehringer Ingelheim
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Boehringer Ingelheim
Role: STUDY_CHAIR
Boehringer Ingelheim
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University Shougang Hospital
Beijing, , China
Beijing Hospital
Beijing, , China
Beijing Pinggu Hospital
Beijing, , China
China Meitan General Hospital
Beijing, , China
First Hospital of Jilin University
Changchun, , China
Chinese Traditional Medicine Hospital of Sichuna Provinc
Chengdu, , China
West China Hospital
Chengdu, , China
First Affiliated Hospital of Dalian Medical University
Dalian, , China
Forth Clinical Hospital of Harbin Medical University
Harbin, , China
The First Affiliated Hospital of Anhui Medical University
Hefei, , China
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, , China
Nanjing First Hospital
Nanjing, , China
Integrated Chinese and Western Medicine Hospital
Nanjing, , China
Affiliated Hospital of Nantong University
Nantong, , China
The affiliated hospital of medicalcollege qingdao university
Qingdao, , China
Shengjing Hospital of China Medical University
Shenyang, , China
Shenzhen People's Hospital
Shenzhen, , China
The First Affiliated Hospital of Soochow University
Suzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1218.174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.